You can have a perfectly designed protocol, a well-resourced site, and a strong PI. None of it matters if you can't answer both.
Finding Patients
Most patients who would qualify for a trial never hear about it. The pipeline problem isn't just a recruitment inefficiency — it's a structural failure in how trials reach eligible individuals.
85% of trials fail to meet enrollment timelines
Phase III delays cost $600K–$8M per day
The majority of eligible patients are never identified
Keeping Them Engaged
Finding patients is hard. Keeping them is harder. Between visits, participants have no meaningful connection to the trial — and that silence compounds into dropout.
Dropout rates routinely exceed 30%
Survey completion sits at 60–70% industry-wide
Every dropout wastes recruitment investment and weakens statistical power
No meaningful connection between site visits
Your CTMS manages operations. Recruitment campaigns push messages at patients. Standalone trial apps get downloaded once and forgotten. None of these make trial participation fit into everyday life.
Configured in Participate. Delivered through Engage.
Most clinical trial platforms treat the participant experience as an afterthought — "here's a portal, log in and take the survey." Flusso built the participant experience first, then built the researcher tools to configure what participants would see. That's why the expected outcomes are so different.
Participate — Your Command Center
You configure everything your trial needs in a single dashboard:
Everything you configure becomes live the moment you publish. No backend work. No delays.
Engage — Their Companion App
Participants experience your trial through the app they already trust — the one they use for GP messages, appointment reminders, and health coordination. They see:
Survey notifications integrated into their normal message stream
Plain-language consent explaining exactly what you're measuring and why
Visit reminders timed to when they'd actually appreciate them
Messages from their trial team when there's something important to say
A way to ask questions without worrying if someone will respond
Participants never need to download a new app. They never need to remember a new login. Your trial lives in the app they're already using.
This two-sided experience is why Participate participants stay enrolled. When participants experience your trial through an app they trust and use daily, response rates go from 60% to 85%+. Dropout goes from 30% to under 10%.
What Flusso adds that your current tools don't.
Flusso includes full clinical trial management — protocol design, visit scheduling, ePRO surveys, site coordination, audit trails, and ICH E6(R3) compliance. It's a working CTMS. But it also does things your current tools can't.
Participant engagement built in — not bolted on
Enterprise platforms like Veeva and Medidata have deep trial operations — eTMF, RTSM, drug supply. But participant-facing capabilities are separate products with separate data models. On Flusso, everything you configure is delivered directly to participants through Engage. One system, one data model.
Retention through experience — not outreach
Site tools like CRIO and RealTime add recruitment campaigns, SMS blasts, and lead tracking. These improve outreach efficiency — but they're still pushing messages through channels patients don't routinely check. Flusso sustains engagement because the trial fits into the app participants use for their everyday healthcare.
One app that lasts — not another download to forget
Standalone trial apps require a new download and a new relationship for every study. Engagement decays because patients have no reason to use the app outside of one trial. Engage handles trial activities and everyday healthcare — so it stays on the home screen long after a single study ends.
Multi-site data sharing without 18-month legal negotiations
No CTMS competitor offers cross-organisation data governance. Data Coalitions let organisations agree to sharing norms once — every subsequent request is auto-validated. Data stays in source systems. Only governance norms travel. Your legal team approves sharing they'd never greenlight elsewhere.
Built on academic research. Shaped by clinical operations experience. Ready for pilots.
The Team Behind Flusso
Prof. Nikolajs Zeps
Director of Cancer Research Operations, Monash University. Co-author, Australian Clinical Trials Handbook. Founding Director, Australian Clinical Trials Alliance. Clinical operations credibility at the founding level.
Ben Szymkow — CEO
Privacy-preserving ML and AI governance. Former Head of Operations at OpenMined. Built Flusso's Contextual Integrity architecture from peer-reviewed foundations.
Andrew Dobbins — CCO
20+ years enterprise sales across APAC and Japan. Former Group VP at Verizon Business. Understands how complex technology decisions get made inside large organisations.
Contextual Integrity Foundation
Helen Nissenbaum, Cornell Tech. 20 years of peer-reviewed research. 5,000+ academic citations. Flusso is the production implementation of this framework — not an interpretation of it.
Pilot Partnership
We're actively seeking research organisations willing to run a study on the platform and help us validate with real data. We don't have published metrics yet. What we have is a platform built on sound architecture, shaped by clinical operations experience, and ready to demonstrate its value in practice.
Dedicated onboarding and configuration support
Full access to Participate and Engage
Direct input into product development
Preferential early-adopter pricing
Next Step
Schedule a 30-minute discovery call. We'll show you the platform configured for your use case — not a generic demo.